Are Your AI Tools Introducing New Compliance Risks in the EU?

Understanding the Intersection of AI and Compliance

Join regulatory and legal experts from Synterex, JURISolutions Legal, Jaguar Health, and AVS Life Science as they explore the real-world impact of GDPR and the EU AI Act on clinical trial systems.

This interactive panel webinar brings together experts in legal, regulatory, and quality domains. They will examine the broader implications of these regulations. Panelists will discuss how GDPR and the AI Act intersect, where they differ, and what these frameworks mean for the future of data-driven innovation in life sciences.

Through moderated questions, attendees will gain practical insights on responsibilities, risks, and compliance strategies while supporting innovation.

Event Details

Date: Wednesday, September 24, 2025

Time: 1:00 - 2:00 PM ET

Read more about the webinar here.

Register

The Importance of Compliance in AI Tools

In the rapidly evolving landscape of biotechnology and pharmaceuticals, compliance is paramount. The introduction of AI tools has transformed data handling and analysis. However, these advancements also bring new compliance challenges.

The General Data Protection Regulation (GDPR) and the EU AI Act are critical frameworks that govern data usage and AI applications. Understanding these regulations is essential for companies aiming to leverage AI effectively while ensuring compliance.

Key Compliance Challenges

1. Data Privacy: GDPR emphasizes the protection of personal data. Companies must ensure that AI tools do not compromise data privacy. This includes obtaining explicit consent for data usage and implementing robust data protection measures.

   
   

2. Transparency: The EU AI Act mandates transparency in AI systems. Organizations must be clear about how AI tools make decisions. This transparency builds trust and ensures accountability.

   
   

3. Risk Assessment: Companies must conduct thorough risk assessments of their AI tools. Identifying potential risks early can prevent compliance issues down the line.

   
   

Strategies for Compliance

To navigate these challenges, organizations should adopt proactive compliance strategies. Here are some effective approaches:

• Regular Training: Conduct regular training sessions for staff on GDPR and the EU AI Act. This ensures that everyone understands their responsibilities regarding data handling and AI usage.

  
  

• Implement Robust Policies: Develop clear policies that outline data handling procedures. These policies should align with GDPR and the EU AI Act requirements.

  
  

• Engage Legal Experts: Collaborate with legal experts to stay updated on regulatory changes. Their insights can help mitigate compliance risks.

  
  

The Future of AI in Life Sciences

As AI continues to evolve, its role in life sciences will expand. Companies must adapt to these changes while maintaining compliance. The intersection of AI and compliance will shape the future of drug development.

By embracing innovative technologies and adhering to regulatory frameworks, organizations can enhance their operational efficiency. This will ultimately lead to faster delivery of new treatments to patients.

In conclusion, understanding the implications of GDPR and the EU AI Act is crucial for biotech and pharmaceutical companies. By prioritizing compliance, organizations can leverage AI tools effectively while mitigating risks.

The journey towards compliance may be complex, but the benefits of innovation and improved patient outcomes make it worthwhile.